HEADER SIGNALING PROTEIN 28-JUL-15 5AAU TITLE OPTIMIZATION OF A NOVEL BINDING MOTIF TO TO (E)-3-(3,5-DIFLUORO-4- TITLE 2 ((1R,3R)-2-(2-FLUORO-2-METHYLPROPYL)-3-METHYL-2,3,4,9-TETRAHYDRO-1H- TITLE 3 PYRIDO(3,4-B)INDOL-1-YL)PHENYL)ACRYLIC ACID (AZD9496), A POTENT AND TITLE 4 ORALLY BIOAVAILABLE SELECTIVE ESTROGEN RECEPTOR DOWNREGULATOR AND TITLE 5 ANTAGONIST COMPND MOL_ID: 1; COMPND 2 MOLECULE: ESTROGEN RECEPTOR; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: LIGAND-BINDING DOMAIN, UNP RESIDUES 307-554; COMPND 5 SYNONYM: ER, ER-ALPHA, ESTRADIOL RECEPTOR, NUCLEAR RECEPTOR SUBFAMILY COMPND 6 3 GROUP A MEMBER 1, ESTROGEN RECEPTOR ALPHA; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VARIANT: GOLD KEYWDS SIGNALING PROTEIN, BREAST CANCER, ESTROGEN RECEPTOR DOWNREGULATOR, KEYWDS 2 FULVESTRANT, AZD9496, NUCLEAR HORMONE RECEPTOR EXPDTA X-RAY DIFFRACTION AUTHOR R.A.NORMAN,R.H.BRADBURY,C.DE ALMEIDA,D.M.ANDREWS,P.BALLARD,D.BUTTAR, AUTHOR 2 R.J.CALLIS,G.S.CURRIE,J.O.CURWEN,C.D.DAVIES,C.DE SAVI,C.S.DONALD, AUTHOR 3 L.J.L.FERON,S.C.GLOSSOP,B.R.HAYTER,G.KAROUTCHI,S.G.LAMONT,P.MACFAUL, AUTHOR 4 T.MOSS,S.E.PEARSON,A.A.RABOW,M.TONGE,G.E.WALKER,H.M.WEIR,Z.WILSON REVDAT 4 01-MAY-24 5AAU 1 REMARK REVDAT 3 12-OCT-16 5AAU 1 REMARK REVDAT 2 04-NOV-15 5AAU 1 JRNL REVDAT 1 14-OCT-15 5AAU 0 JRNL AUTH C.DE SAVI,R.H.BRADBURY,A.A.RABOW,R.A.NORMAN,C.DE ALMEIDA, JRNL AUTH 2 D.M.ANDREWS,P.BALLARD,D.BUTTAR,R.CALLIS,G.S.CURRIE,C.DAVIES, JRNL AUTH 3 C.DONALD,L.FERON,B.R.HAYTER,S.HUSSAIN,G.KAROUTCHI,S.LAMONT, JRNL AUTH 4 P.A.MACFAUL,T.A.MOSS,S.PEARSON,M.TONGE,G.WALKER,H.WEIR, JRNL AUTH 5 Z.WILSON JRNL TITL OPTIMIZATION OF A NOVEL BINDING MOTIF TO JRNL TITL 2 (E)-3-(3,5-DIFLUORO-4-((1R,3R)-2-(2-FLUORO-2-METHYLPROPYL) JRNL TITL 3 -3-METHYL-2, JRNL TITL 4 3,4,9-TETRAHYDRO-1H-PYRIDO[3,4-B]INDOL-1-YL)PHENYL)ACRYLIC JRNL TITL 5 ACID (AZD9496), A POTENT AND ORALLY BIOAVAILABLE SELECTIVE JRNL TITL 6 ESTROGEN RECEPTOR DOWNREGULATOR AND ANTAGONIST. JRNL REF J.MED.CHEM. V. 58 8128 2015 JRNL REFN ISSN 0022-2623 JRNL PMID 26407012 JRNL DOI 10.1021/ACS.JMEDCHEM.5B00984 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH H.M.WEIR,R.H.BRADBURY,M.LAWSON,A.A.RABOW,D.BUTTAR, REMARK 1 AUTH 2 R.J.CALLIS,J.O.CURWEN,C.DE ALMEIDA,P.BALLARD,M.HULSE, REMARK 1 AUTH 3 C.S.DONALD,L.J.L.FERON,G.KAROUTCHI,P.MACFAUL,T.MOSS, REMARK 1 AUTH 4 R.A.NORMAN,S.E.PEARSON,M.TONGE,G.DAVIES,G.E.WALKER,Z.WILSON, REMARK 1 AUTH 5 R.ROWLINSON,S.POWELL,C.SADLER,G.RICHMOND,B.LADD,E.PAZOLLI, REMARK 1 AUTH 6 A.M.MAZZOLA,C.D'CRUZ,C.DE SAVI REMARK 1 TITL AZD9496: AN ORAL ESTROGEN RECEPTOR INHIBITOR THAT BLOCKS THE REMARK 1 TITL 2 GROWTH OF ER-POSITIVE AND ESR1-MUTANT BREAST TUMORS IN REMARK 1 TITL 3 PRECLINICAL MODELS. REMARK 1 REF CANCER RES. V. 76 3307 2016 REMARK 1 REFN ISSN 0008-5472 REMARK 1 PMID 27020862 REMARK 1 DOI 10.1158/0008-5472.CAN-15-2357 REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0103 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 25.70 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 90.9 REMARK 3 NUMBER OF REFLECTIONS : 31453 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.176 REMARK 3 R VALUE (WORKING SET) : 0.173 REMARK 3 FREE R VALUE : 0.226 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 1629 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.90 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.95 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1279 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 50.72 REMARK 3 BIN R VALUE (WORKING SET) : 0.3040 REMARK 3 BIN FREE R VALUE SET COUNT : 55 REMARK 3 BIN FREE R VALUE : 0.2880 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3532 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 50 REMARK 3 SOLVENT ATOMS : 227 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 28.40 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.18000 REMARK 3 B22 (A**2) : -0.51000 REMARK 3 B33 (A**2) : 0.33000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.02000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.171 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.159 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.121 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 9.516 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.962 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.938 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3764 ; 0.024 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 3637 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5122 ; 2.104 ; 1.986 REMARK 3 BOND ANGLES OTHERS (DEGREES): 8346 ; 1.149 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 474 ; 5.945 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 156 ;37.298 ;23.974 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 670 ;15.451 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 19 ;21.983 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 600 ; 0.137 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4178 ; 0.012 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 841 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1837 ; 1.803 ; 2.359 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1836 ; 1.791 ; 2.358 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2293 ; 2.734 ; 3.506 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1927 ; 2.389 ; 2.608 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 303 A 552 REMARK 3 ORIGIN FOR THE GROUP (A): 8.2355 -0.1037 22.8836 REMARK 3 T TENSOR REMARK 3 T11: 0.0199 T22: 0.0258 REMARK 3 T33: 0.0085 T12: 0.0181 REMARK 3 T13: 0.0002 T23: 0.0006 REMARK 3 L TENSOR REMARK 3 L11: 1.0167 L22: 0.4551 REMARK 3 L33: 1.0224 L12: -0.3181 REMARK 3 L13: 0.0497 L23: -0.3365 REMARK 3 S TENSOR REMARK 3 S11: 0.0253 S12: -0.0452 S13: -0.0235 REMARK 3 S21: -0.0132 S22: 0.0465 S23: 0.0157 REMARK 3 S31: -0.0658 S32: -0.0883 S33: -0.0719 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. U VALUES WITH TLS ADDED REMARK 4 REMARK 4 5AAU COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 28-JUL-15. REMARK 100 THE DEPOSITION ID IS D_1290064510. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I04 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.96 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 31454 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 85.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 91.0 REMARK 200 DATA REDUNDANCY : 3.300 REMARK 200 R MERGE (I) : 0.04000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 15.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.00 REMARK 200 COMPLETENESS FOR SHELL (%) : 57.3 REMARK 200 DATA REDUNDANCY IN SHELL : 2.30 REMARK 200 R MERGE FOR SHELL (I) : 0.48000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: IN HOUSE MODEL REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.50 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.07 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M PCTP, PH 6.5 (0.04 M SODIUM REMARK 280 PROPIONATE, 0.02 M SODIUM CACODYLATE, 0.04 M BIS-TRIS PROPANE), REMARK 280 22% PEG3350, 0.2M MGCL2 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 53.20350 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 25.69800 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 53.20350 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 25.69800 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2970 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18880 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -13.1 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP A 332 REMARK 465 PRO A 333 REMARK 465 THR A 334 REMARK 465 ARG A 335 REMARK 465 PRO A 336 REMARK 465 PHE A 337 REMARK 465 SER A 338 REMARK 465 GLU A 339 REMARK 465 ALA A 340 REMARK 465 LEU A 462 REMARK 465 SER A 463 REMARK 465 SER A 464 REMARK 465 THR A 465 REMARK 465 LEU A 466 REMARK 465 LYS A 467 REMARK 465 SER A 468 REMARK 465 LEU A 469 REMARK 465 LYS A 529 REMARK 465 CYS A 530 REMARK 465 LYS A 531 REMARK 465 ASN A 532 REMARK 465 THR A 553 REMARK 465 SER A 554 REMARK 465 GLY B 303 REMARK 465 SER B 304 REMARK 465 HIS B 305 REMARK 465 MET B 306 REMARK 465 ALA B 307 REMARK 465 LEU B 308 REMARK 465 SER B 309 REMARK 465 ASP B 332 REMARK 465 PRO B 333 REMARK 465 THR B 334 REMARK 465 ARG B 335 REMARK 465 SER B 464 REMARK 465 THR B 465 REMARK 465 LEU B 466 REMARK 465 LYS B 467 REMARK 465 SER B 468 REMARK 465 LEU B 469 REMARK 465 GLU B 470 REMARK 465 LYS B 529 REMARK 465 CYS B 530 REMARK 465 LYS B 531 REMARK 465 ASN B 532 REMARK 465 HIS B 547 REMARK 465 ARG B 548 REMARK 465 LEU B 549 REMARK 465 HIS B 550 REMARK 465 ALA B 551 REMARK 465 PRO B 552 REMARK 465 THR B 553 REMARK 465 SER B 554 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 397 CG CD OE1 OE2 REMARK 470 LYS A 416 CG CD CE NZ REMARK 470 GLU A 419 CG CD OE1 OE2 REMARK 470 GLU A 470 CG CD OE1 OE2 REMARK 470 LYS A 472 CG CD CE NZ REMARK 470 LYS A 492 CD CE NZ REMARK 470 PHE B 337 CG CD1 CD2 CE1 CE2 CZ REMARK 470 HIS B 373 CG ND1 CD2 CE1 NE2 REMARK 470 LYS B 416 CG CD CE NZ REMARK 470 GLU B 419 CG CD OE1 OE2 REMARK 470 GLU B 423 CG CD OE1 OE2 REMARK 470 MET B 437 SD CE REMARK 470 ASN B 439 CG OD1 ND2 REMARK 470 GLU B 471 CG CD OE1 OE2 REMARK 470 LYS B 472 CG CD CE NZ REMARK 470 ARG B 477 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 492 CG CD CE NZ REMARK 470 VAL B 533 CG1 CG2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH B 2070 O HOH B 2074 2.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 ND2 ASN A 359 OH TYR B 328 3545 1.77 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 ARG A 352 CZ ARG A 352 NH2 0.086 REMARK 500 TRP B 383 CB TRP B 383 CG -0.118 REMARK 500 GLU B 385 CD GLU B 385 OE1 -0.083 REMARK 500 MET B 388 C MET B 388 O 0.114 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 313 CB - CG - OD1 ANGL. DEV. = 6.2 DEGREES REMARK 500 ASP A 321 CB - CG - OD1 ANGL. DEV. = 5.7 DEGREES REMARK 500 ARG A 436 NE - CZ - NH1 ANGL. DEV. = 5.0 DEGREES REMARK 500 ARG A 436 NE - CZ - NH2 ANGL. DEV. = -3.8 DEGREES REMARK 500 ARG A 515 CG - CD - NE ANGL. DEV. = -14.0 DEGREES REMARK 500 ARG A 515 NE - CZ - NH2 ANGL. DEV. = -3.1 DEGREES REMARK 500 ARG B 394 CG - CD - NE ANGL. DEV. = 13.0 DEGREES REMARK 500 ARG B 515 NE - CZ - NH1 ANGL. DEV. = 3.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 408 76.40 -153.57 REMARK 500 SER B 527 35.03 -81.21 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE XBR A 1553 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE XBR B 1547 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5AAV RELATED DB: PDB REMARK 900 OPTIMIZATION OF A NOVEL BINDING MOTIF TO TO (E)-3-( 3,5-DIFLUORO-4- REMARK 900 ((1R,3R)-2-(2-FLUORO-2-METHYLPROPYL )-3-METHYL-2,3,4,9-TETRAHYDRO- REMARK 900 1H-PYRIDO(3,4-B) INDOL-1-YL)PHENYL)ACRYLIC ACID (AZD9496), A POTENT REMARK 900 AND ORALLY BIOAVAILABLE SELECTIVE ESTROGEN RECEPTOR DOWNREGULATOR REMARK 900 AND ANTAGONIST DBREF 5AAU A 307 554 UNP P03372 ESR1_HUMAN 307 554 DBREF 5AAU B 307 554 UNP P03372 ESR1_HUMAN 307 554 SEQADV 5AAU GLY A 303 UNP P03372 EXPRESSION TAG SEQADV 5AAU SER A 304 UNP P03372 EXPRESSION TAG SEQADV 5AAU HIS A 305 UNP P03372 EXPRESSION TAG SEQADV 5AAU MET A 306 UNP P03372 EXPRESSION TAG SEQADV 5AAU SER A 381 UNP P03372 CYS 381 ENGINEERED MUTATION SEQADV 5AAU SER A 417 UNP P03372 CYS 417 ENGINEERED MUTATION SEQADV 5AAU SER A 536 UNP P03372 LEU 536 ENGINEERED MUTATION SEQADV 5AAU GLY B 303 UNP P03372 EXPRESSION TAG SEQADV 5AAU SER B 304 UNP P03372 EXPRESSION TAG SEQADV 5AAU HIS B 305 UNP P03372 EXPRESSION TAG SEQADV 5AAU MET B 306 UNP P03372 EXPRESSION TAG SEQADV 5AAU SER B 381 UNP P03372 CYS 381 ENGINEERED MUTATION SEQADV 5AAU SER B 417 UNP P03372 CYS 417 ENGINEERED MUTATION SEQADV 5AAU SER B 536 UNP P03372 LEU 536 ENGINEERED MUTATION SEQRES 1 A 252 GLY SER HIS MET ALA LEU SER LEU THR ALA ASP GLN MET SEQRES 2 A 252 VAL SER ALA LEU LEU ASP ALA GLU PRO PRO ILE LEU TYR SEQRES 3 A 252 SER GLU TYR ASP PRO THR ARG PRO PHE SER GLU ALA SER SEQRES 4 A 252 MET MET GLY LEU LEU THR ASN LEU ALA ASP ARG GLU LEU SEQRES 5 A 252 VAL HIS MET ILE ASN TRP ALA LYS ARG VAL PRO GLY PHE SEQRES 6 A 252 VAL ASP LEU THR LEU HIS ASP GLN VAL HIS LEU LEU GLU SEQRES 7 A 252 SER ALA TRP LEU GLU ILE LEU MET ILE GLY LEU VAL TRP SEQRES 8 A 252 ARG SER MET GLU HIS PRO GLY LYS LEU LEU PHE ALA PRO SEQRES 9 A 252 ASN LEU LEU LEU ASP ARG ASN GLN GLY LYS SER VAL GLU SEQRES 10 A 252 GLY MET VAL GLU ILE PHE ASP MET LEU LEU ALA THR SER SEQRES 11 A 252 SER ARG PHE ARG MET MET ASN LEU GLN GLY GLU GLU PHE SEQRES 12 A 252 VAL CYS LEU LYS SER ILE ILE LEU LEU ASN SER GLY VAL SEQRES 13 A 252 TYR THR PHE LEU SER SER THR LEU LYS SER LEU GLU GLU SEQRES 14 A 252 LYS ASP HIS ILE HIS ARG VAL LEU ASP LYS ILE THR ASP SEQRES 15 A 252 THR LEU ILE HIS LEU MET ALA LYS ALA GLY LEU THR LEU SEQRES 16 A 252 GLN GLN GLN HIS GLN ARG LEU ALA GLN LEU LEU LEU ILE SEQRES 17 A 252 LEU SER HIS ILE ARG HIS MET SER ASN LYS GLY MET GLU SEQRES 18 A 252 HIS LEU TYR SER MET LYS CYS LYS ASN VAL VAL PRO SER SEQRES 19 A 252 TYR ASP LEU LEU LEU GLU MET LEU ASP ALA HIS ARG LEU SEQRES 20 A 252 HIS ALA PRO THR SER SEQRES 1 B 252 GLY SER HIS MET ALA LEU SER LEU THR ALA ASP GLN MET SEQRES 2 B 252 VAL SER ALA LEU LEU ASP ALA GLU PRO PRO ILE LEU TYR SEQRES 3 B 252 SER GLU TYR ASP PRO THR ARG PRO PHE SER GLU ALA SER SEQRES 4 B 252 MET MET GLY LEU LEU THR ASN LEU ALA ASP ARG GLU LEU SEQRES 5 B 252 VAL HIS MET ILE ASN TRP ALA LYS ARG VAL PRO GLY PHE SEQRES 6 B 252 VAL ASP LEU THR LEU HIS ASP GLN VAL HIS LEU LEU GLU SEQRES 7 B 252 SER ALA TRP LEU GLU ILE LEU MET ILE GLY LEU VAL TRP SEQRES 8 B 252 ARG SER MET GLU HIS PRO GLY LYS LEU LEU PHE ALA PRO SEQRES 9 B 252 ASN LEU LEU LEU ASP ARG ASN GLN GLY LYS SER VAL GLU SEQRES 10 B 252 GLY MET VAL GLU ILE PHE ASP MET LEU LEU ALA THR SER SEQRES 11 B 252 SER ARG PHE ARG MET MET ASN LEU GLN GLY GLU GLU PHE SEQRES 12 B 252 VAL CYS LEU LYS SER ILE ILE LEU LEU ASN SER GLY VAL SEQRES 13 B 252 TYR THR PHE LEU SER SER THR LEU LYS SER LEU GLU GLU SEQRES 14 B 252 LYS ASP HIS ILE HIS ARG VAL LEU ASP LYS ILE THR ASP SEQRES 15 B 252 THR LEU ILE HIS LEU MET ALA LYS ALA GLY LEU THR LEU SEQRES 16 B 252 GLN GLN GLN HIS GLN ARG LEU ALA GLN LEU LEU LEU ILE SEQRES 17 B 252 LEU SER HIS ILE ARG HIS MET SER ASN LYS GLY MET GLU SEQRES 18 B 252 HIS LEU TYR SER MET LYS CYS LYS ASN VAL VAL PRO SER SEQRES 19 B 252 TYR ASP LEU LEU LEU GLU MET LEU ASP ALA HIS ARG LEU SEQRES 20 B 252 HIS ALA PRO THR SER HET XBR A1553 25 HET XBR B1547 25 HETNAM XBR 3-(1-(4-CHLOROPHENYL)-3,4-DIHYDRO-1H-PYRIDO(3,4-B) HETNAM 2 XBR INDOL-2(9H)-YL)PROPANOIC ACID FORMUL 3 XBR 2(C20 H19 CL N2 O2) FORMUL 5 HOH *227(H2 O) HELIX 1 1 MET A 306 LEU A 310 5 5 HELIX 2 2 THR A 311 GLU A 323 1 13 HELIX 3 3 SER A 341 ARG A 363 1 23 HELIX 4 4 GLY A 366 LEU A 370 5 5 HELIX 5 5 THR A 371 MET A 396 1 26 HELIX 6 6 ARG A 412 LYS A 416 1 5 HELIX 7 7 GLY A 420 MET A 438 1 19 HELIX 8 8 GLN A 441 SER A 456 1 16 HELIX 9 9 GLU A 470 ALA A 493 1 24 HELIX 10 10 THR A 496 MET A 528 1 33 HELIX 11 11 SER A 536 HIS A 547 1 12 HELIX 12 12 ARG A 548 HIS A 550 5 3 HELIX 13 13 THR B 311 ALA B 322 1 12 HELIX 14 14 SER B 338 ARG B 363 1 26 HELIX 15 15 GLY B 366 LEU B 370 5 5 HELIX 16 16 THR B 371 MET B 396 1 26 HELIX 17 17 ARG B 412 LYS B 416 1 5 HELIX 18 18 GLY B 420 MET B 438 1 19 HELIX 19 19 GLN B 441 SER B 456 1 16 HELIX 20 20 GLU B 471 ALA B 493 1 23 HELIX 21 21 THR B 496 SER B 527 1 32 HELIX 22 22 SER B 536 ALA B 546 1 11 SHEET 1 AA 2 LYS A 401 ALA A 405 0 SHEET 2 AA 2 LEU A 408 ASP A 411 -1 O LEU A 408 N ALA A 405 SHEET 1 BA 2 LYS B 401 ALA B 405 0 SHEET 2 BA 2 LEU B 408 ASP B 411 -1 O LEU B 408 N ALA B 405 SITE 1 AC1 11 LEU A 346 THR A 347 ALA A 350 GLU A 353 SITE 2 AC1 11 LEU A 387 PHE A 404 ILE A 424 GLY A 521 SITE 3 AC1 11 HIS A 524 LEU A 525 VAL A 533 SITE 1 AC2 11 LEU B 346 THR B 347 LEU B 349 LEU B 387 SITE 2 AC2 11 ARG B 394 MET B 421 ILE B 424 GLY B 521 SITE 3 AC2 11 HIS B 524 LEU B 525 VAL B 533 CRYST1 106.407 51.396 85.181 90.00 93.66 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009398 0.000000 0.000601 0.00000 SCALE2 0.000000 0.019457 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011764 0.00000